![High uptake and use of vaginal ring for HIV prevention observed in open-label study | National Institutes of Health (NIH) High uptake and use of vaginal ring for HIV prevention observed in open-label study | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/featured_media_breakpoint-medium/public/news-events/news-releases/2018/20180306-woman-ring.jpg?itok=P3OHbcvi×tamp=1520352825)
High uptake and use of vaginal ring for HIV prevention observed in open-label study | National Institutes of Health (NIH)
![InfoNile on Twitter: "Edit Tweet: The dapivirine ring reduces HIV/AIDS contraction by 50%. In 2018 , there were 800,000 HIV cases in Sub-Saharan Africa; of those, 208,000 were women between 15-24 years ( InfoNile on Twitter: "Edit Tweet: The dapivirine ring reduces HIV/AIDS contraction by 50%. In 2018 , there were 800,000 HIV cases in Sub-Saharan Africa; of those, 208,000 were women between 15-24 years (](https://pbs.twimg.com/media/FThO6riWUAMQrf2.jpg:large)
InfoNile on Twitter: "Edit Tweet: The dapivirine ring reduces HIV/AIDS contraction by 50%. In 2018 , there were 800,000 HIV cases in Sub-Saharan Africa; of those, 208,000 were women between 15-24 years (
![UNAIDS is hopeful that a new long-acting HIV prevention option will soon become available for women in sub-Saharan Africa | UNAIDS UNAIDS is hopeful that a new long-acting HIV prevention option will soon become available for women in sub-Saharan Africa | UNAIDS](https://www.unaids.org/sites/default/files/styles/webstory_ptohogallerytopimage/public/dapirivine-ring-1-1020x610_960.jpg?itok=k4S6rVsA)
UNAIDS is hopeful that a new long-acting HIV prevention option will soon become available for women in sub-Saharan Africa | UNAIDS
![European Medicines Agency (EMA) approval of the dapivirine ring for HIV prevention for women in high HIV burden settings European Medicines Agency (EMA) approval of the dapivirine ring for HIV prevention for women in high HIV burden settings](https://www.who.int/images/default-source/departments/hiv/dpv-vr-1500.jpg?sfvrsn=cb7c175e_2)
European Medicines Agency (EMA) approval of the dapivirine ring for HIV prevention for women in high HIV burden settings
![Put a ring on it: Four reasons to make the dapivirine ring an HIV prevention option for women and girls - Degrees Put a ring on it: Four reasons to make the dapivirine ring an HIV prevention option for women and girls - Degrees](https://degrees.fhi360.org/wp-content/uploads/2020/07/hiv-ring-in-hand-blog-850X567.jpg)